Clinical Trial Update: Immunotherapy in Treating Patients With Metastatic Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update on immunotherapy for metastatic breast cancer spanning Phase 1 and Phase 2 that has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Duke University | Conditions: Breast Cancer | Phase 1, Phase 2 | Status: TERMINATED